- next ›
- last »
There are distinct differences in the basic design criteria between semiconductorand biopharma cleanrooms — starting with the floors, ceilings, and walls.As the CEO of a cleanroom room design/build company, a turnkey serviceprovider for the life science industries, I’m frequently asked, “So, how’d youget into this?” And the answer is always the same — a long-winded monologueon how I started my career in the mid-1990s working for a subcontractor inSilicon Valley and how, due to a shift in capital expenditures, I was motivatedto make a move away from semiconductor and focus instead on biopharmaceutical and health care. The not-so-subtle theme of follow the money alwaysraises eyebrows and gets the slow but affirmative nod of approval, but whatseems to get lost in translation are the reasons why such a move was necessary;that is, there are distinct differences in the basic design criteria betweensemiconductor and biopharma which make the engineering and constructionof their cleanroom environments a mutually exclusive process.For years, I witnessed cleanroom vendors and contractors grosslycannibalize semiconductor products in unsuccessful attempts atcreating acceptable life science systems. It’s fair to say that the lackof understanding by professionals on all sides of both industries — designers,manufacturers, contractors, and end users — have slowed the process ofinnovation. It has resulted in many companies accepting products thatdon’t perform to the highest standards which have ultimately increasedcosts and slowed production.The most commonly understood element of their incompatibility is in thecontrasting nature of their exposed surface materials — the floors, walls,and ceilings. This is due to the obvious fact that the performance criteria of thearchitectural surfaces in a semiconductor facility are completely oppositeto those in a life science laboratory. A somewhat typical semiconductor